Treatments for depression and other diseases with a low dose agent
US9278094B2 · kind B2 · utility
3Cited by
12References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 5, 2015 |
| Grant date | Mar 8, 2016 |
| Priority date | — |
| Expiry date | Mar 5, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to improved compositions and methods for the treatment or prevention of various diseases, including forms of depression, including, for example, breakthrough depression and treatment-refractory depression, and other mood disorders, as well as Parkinson's disease, bipolar disorder, bipolar disorder, attention deficit disorder (ADHD), Restless Leg Syndrome (RLS), and obesity. In some embodiments, the compositions and methods comprise low dose naltrexone or related opioid antagonists.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.